(-)-epigallocatechin 3-gallate increases expression ISO FAT1 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of FAT1 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO FAT1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FAT1 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO Fat1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAT1 mRNA CTD PMID:36331819 (S)-nicotine increases expression ISO FAT1 (Homo sapiens) 6480464 Nicotine results in increased expression of FAT1 mRNA CTD PMID:16949557 1,1-dichloroethene increases expression ISO Fat1 (Mus musculus) 6480464 vinylidene chloride results in increased expression of FAT1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine affects expression ISO Fat1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of FAT1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FAT1 mRNA CTD PMID:25380136 and PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of FAT1 mRNA CTD PMID:17557909 17beta-estradiol decreases expression ISO FAT1 (Homo sapiens) 6480464 Estradiol results in decreased expression of FAT1 mRNA CTD PMID:21185374 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FAT1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO FAT1 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of FAT1 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO FAT1 (Homo sapiens) 6480464 Estradiol results in increased expression of FAT1 mRNA CTD PMID:23019147 and PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO FAT1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of FAT1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fat1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAT1 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO FAT1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAT1 mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fat1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FAT1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FAT1 mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FAT1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of FAT1 mRNA] CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of FAT1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of FAT1 mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO Fat1 (Mus musculus) 6480464 n-butoxyethanol results in decreased expression of FAT1 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO FAT1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of FAT1 mRNA CTD PMID:30851411 2-nitrotoluene decreases expression EXP 6480464 2-nitrotoluene results in decreased expression of FAT1 mRNA CTD PMID:16460773 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of FAT1 mRNA and Puromycin Aminonucleoside results in increased expression of FAT1 protein CTD PMID:16014031 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FAT1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAT1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAT1 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FAT1 mRNA CTD PMID:25380136 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of FAT1 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO Fat1 (Mus musculus) 6480464 Fenretinide results in increased expression of FAT1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FAT1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FAT1 mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of FAT1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO FAT1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FAT1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FAT1 mRNA CTD PMID:32699268 afimoxifene decreases expression ISO Fat1 (Mus musculus) 6480464 afimoxifene results in decreased expression of FAT1 mRNA CTD PMID:26879975 aflatoxin B1 increases expression ISO FAT1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of FAT1 mRNA CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of FAT1 mRNA CTD PMID:33354967 all-trans-retinoic acid decreases expression ISO FAT1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of FAT1 mRNA CTD PMID:15498508 and PMID:23724009 alpha-pinene multiple interactions ISO FAT1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FAT1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FAT1 mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of FAT1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FAT1 mRNA CTD PMID:16483693 arecoline increases expression ISO Fat1 (Mus musculus) 151347668 arecoline cotreated with dimethyl sulfoxide increases expression of Fat1 protein in tongue RGD aristolochic acid A decreases expression ISO FAT1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of FAT1 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO FAT1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FAT1 mRNA CTD PMID:25555879 arsenous acid increases expression ISO FAT1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FAT1 mRNA CTD PMID:25555879 atrazine increases expression ISO FAT1 (Homo sapiens) 6480464 Atrazine results in increased expression of FAT1 mRNA CTD PMID:18585445 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of FAT1 gene CTD PMID:35440735 benzo[a]pyrene decreases expression ISO FAT1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of FAT1 mRNA CTD PMID:20106945 and PMID:21632981 benzo[a]pyrene increases expression ISO Fat1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FAT1 mRNA CTD PMID:19770486 and PMID:22610609 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FAT1 promoter CTD PMID:23359474 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FAT1 promoter and [bisphenol A co-treated with Genistein] results in increased methylation of FAT1 gene CTD PMID:23359474 and PMID:28505145 bisphenol A affects methylation ISO FAT1 (Homo sapiens) 6480464 bisphenol A affects the methylation of FAT1 gene CTD PMID:31601247 bisphenol A increases expression ISO Fat1 (Mus musculus) 6480464 bisphenol A results in increased expression of FAT1 mRNA CTD PMID:32370801 and PMID:35598803 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FAT1 mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A multiple interactions ISO Fat1 (Mus musculus) 6480464 [bisphenol A co-treated with LIF protein] results in decreased expression of FAT1 mRNA CTD PMID:30951980 bisphenol A increases expression ISO FAT1 (Homo sapiens) 6480464 bisphenol A results in increased expression of FAT1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO FAT1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FAT1 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAT1 mRNA CTD PMID:28628672 and PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FAT1 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FAT1 mRNA CTD PMID:25181051 and PMID:32145629 bisphenol F multiple interactions ISO FAT1 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of FAT1 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAT1 mRNA CTD PMID:28628672 and PMID:31601247 bromochloroacetic acid decreases expression EXP 6480464 bromochloroacetic acid results in decreased expression of FAT1 mRNA CTD PMID:16460773 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of FAT1 mRNA CTD PMID:24136188 cadmium dichloride multiple interactions ISO FAT1 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of FAT1 mRNA CTD PMID:12634122 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FAT1 mRNA CTD PMID:33453195 caffeine affects phosphorylation ISO FAT1 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of FAT1 protein CTD PMID:35688186 captan increases expression ISO Fat1 (Mus musculus) 6480464 Captan results in increased expression of FAT1 mRNA CTD PMID:31558096 chloropicrin decreases expression ISO FAT1 (Homo sapiens) 6480464 chloropicrin results in decreased expression of FAT1 mRNA CTD PMID:26352163 and PMID:28476498 chlorpyrifos decreases expression ISO Fat1 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of FAT1 mRNA CTD PMID:37019170 choline multiple interactions ISO Fat1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FAT1 gene CTD PMID:20938992 chromium(6+) decreases expression ISO FAT1 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of FAT1 mRNA CTD PMID:30690063 clobetasol decreases expression ISO Fat1 (Mus musculus) 6480464 Clobetasol results in decreased expression of FAT1 mRNA CTD PMID:27462272 clofibrate decreases expression ISO Fat1 (Mus musculus) 6480464 Clofibrate results in decreased expression of FAT1 mRNA CTD PMID:23811191 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of FAT1 mRNA CTD PMID:17602206 copper atom increases expression EXP 6480464 Copper results in increased expression of FAT1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of FAT1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO FAT1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of FAT1 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FAT1 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO FAT1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of FAT1 mRNA CTD PMID:20106945 and PMID:27989131 dexamethasone multiple interactions ISO FAT1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAT1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAT1 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO FAT1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FAT1 mRNA CTD PMID:25555879 diarsenic trioxide increases expression ISO FAT1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FAT1 mRNA CTD PMID:25555879 dibenzofurans decreases expression ISO Fat1 (Mus musculus) 6480464 Dibenzofurans results in decreased expression of FAT1 mRNA CTD PMID:34254344 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FAT1 mRNA CTD PMID:17379624 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of FAT1 promoter CTD PMID:23359474 dichromium trioxide multiple interactions ISO FAT1 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of FAT1 mRNA CTD PMID:12634122 dicrotophos increases expression ISO FAT1 (Homo sapiens) 6480464 dicrotophos results in increased expression of FAT1 mRNA CTD PMID:28302478 doxorubicin increases expression ISO FAT1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of FAT1 mRNA CTD PMID:29803840 epoxiconazole decreases expression ISO Fat1 (Mus musculus) 6480464 epoxiconazole results in decreased expression of FAT1 mRNA CTD PMID:35436446 ethanol increases expression ISO Fat1 (Mus musculus) 6480464 Ethanol results in increased expression of FAT1 mRNA CTD PMID:30319688 fenamidone increases expression ISO Fat1 (Mus musculus) 6480464 fenamidone results in increased expression of FAT1 mRNA CTD PMID:27029645 fenthion decreases expression ISO Fat1 (Mus musculus) 6480464 Fenthion results in decreased expression of FAT1 mRNA CTD PMID:34813904 flutamide increases expression EXP 6480464 Flutamide results in increased expression of FAT1 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of FAT1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO Fat1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FAT1 gene CTD PMID:20938992 folpet increases expression ISO Fat1 (Mus musculus) 6480464 folpet results in increased expression of FAT1 mRNA CTD PMID:31558096 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of FAT1 mRNA alternative form CTD PMID:37263556 formaldehyde multiple interactions EXP 6480464 FAT1 mRNA alternative form promotes the reaction [Formaldehyde results in decreased expression of MIR128] and FAT1 mRNA alternative form promotes the reaction [Formaldehyde results in increased expression of MAPK14 protein] CTD PMID:37263556 fulvestrant multiple interactions ISO FAT1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FAT1 gene and [bisphenol F co-treated with Fulvestrant] results in decreased methylation of FAT1 gene CTD PMID:31601247 genistein decreases expression EXP 6480464 Genistein results in decreased expression of FAT1 mRNA CTD PMID:12075121 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of FAT1 gene CTD PMID:28505145 glyphosate affects methylation EXP 6480464 glyphosate affects the methylation of FAT1 gene CTD PMID:35440735 indometacin multiple interactions ISO FAT1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAT1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAT1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO FAT1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of FAT1 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO FAT1 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Ascorbic Acid] results in increased expression of FAT1 mRNA CTD PMID:25555879 L-ascorbic acid increases expression ISO FAT1 (Homo sapiens) 6480464 Ascorbic Acid results in increased expression of FAT1 mRNA CTD PMID:25555879 L-methionine multiple interactions ISO Fat1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FAT1 gene CTD PMID:20938992 lead diacetate multiple interactions ISO FAT1 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of FAT1 mRNA CTD PMID:12634122 methimazole increases expression EXP 6480464 Methimazole results in increased expression of FAT1 mRNA CTD PMID:30047161 mitomycin C affects response to substance ISO FAT1 (Homo sapiens) 6480464 FAT1 protein affects the susceptibility to Mitomycin CTD PMID:16217747 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of FAT1 mRNA CTD PMID:22087261 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of FAT1 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FAT1 mRNA CTD PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of FAT1 mRNA CTD PMID:25380136 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of FAT1 mRNA CTD PMID:19716841 nicotine increases expression ISO FAT1 (Homo sapiens) 6480464 Nicotine results in increased expression of FAT1 mRNA CTD PMID:16949557 NS-398 increases expression ISO FAT1 (Homo sapiens) 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of FAT1 mRNA CTD PMID:11494140 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FAT1 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of FAT1 mRNA CTD PMID:25729387 ozone multiple interactions ISO FAT1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FAT1 mRNA more ... CTD PMID:32699268 paracetamol affects expression ISO Fat1 (Mus musculus) 6480464 Acetaminophen affects the expression of FAT1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FAT1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO FAT1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FAT1 mRNA CTD PMID:21420995 paraquat increases expression EXP 6480464 Paraquat results in increased expression of FAT1 mRNA CTD PMID:32680482 parathion decreases expression ISO Fat1 (Mus musculus) 6480464 Parathion results in decreased expression of FAT1 mRNA CTD PMID:34813904 perfluorooctane-1-sulfonic acid multiple interactions ISO Fat1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAT1 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO FAT1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of FAT1 mRNA CTD PMID:25812627 perfluorooctanoic acid increases expression ISO FAT1 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of FAT1 mRNA CTD PMID:25812627 phenobarbital increases expression ISO Fat1 (Mus musculus) 6480464 Phenobarbital results in increased expression of FAT1 mRNA CTD PMID:19482888 phenobarbital multiple interactions ISO Fat1 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FAT1 mRNA] CTD PMID:19482888 potassium chromate multiple interactions ISO FAT1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FAT1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO FAT1 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of FAT1 mRNA CTD PMID:22079256 and PMID:22714537 potassium dichromate increases expression ISO Fat1 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of FAT1 mRNA CTD PMID:23608068 Ptaquiloside decreases expression ISO Fat1 (Mus musculus) 6480464 ptaquiloside results in decreased expression of FAT1 mRNA CTD PMID:23274088 quercetin decreases expression ISO FAT1 (Homo sapiens) 6480464 Quercetin results in decreased expression of FAT1 protein CTD PMID:19207037 rac-lactic acid increases expression ISO FAT1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of FAT1 mRNA CTD PMID:30851411 rotenone increases expression ISO FAT1 (Homo sapiens) 6480464 Rotenone results in increased expression of FAT1 mRNA CTD PMID:29955902 Securinine increases expression ISO FAT1 (Homo sapiens) 6480464 securinine results in increased expression of FAT1 mRNA CTD PMID:32662633 sevoflurane decreases methylation ISO Fat1 (Mus musculus) 6480464 Sevoflurane results in decreased methylation of FAT1 mRNA CTD PMID:35249202 sodium arsenite multiple interactions ISO FAT1 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of FAT1 mRNA CTD PMID:12634122 sodium arsenite increases expression ISO Fat1 (Mus musculus) 6480464 sodium arsenite results in increased expression of FAT1 mRNA CTD PMID:36209798 sodium dichromate increases expression ISO Fat1 (Mus musculus) 6480464 sodium bichromate results in increased expression of FAT1 mRNA CTD PMID:31558096 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of FAT1 mRNA CTD PMID:30047161 tamibarotene affects expression ISO FAT1 (Homo sapiens) 6480464 tamibarotene affects the expression of FAT1 mRNA CTD PMID:15498508 temozolomide decreases expression ISO FAT1 (Homo sapiens) 6480464 Temozolomide results in decreased expression of FAT1 mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO Fat1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of FAT1 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FAT1 mRNA CTD PMID:23411599 and PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FAT1 mRNA CTD PMID:28943392 topotecan increases expression EXP 6480464 Topotecan results in increased expression of FAT1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FAT1 mRNA CTD PMID:25729387 valproic acid decreases methylation ISO FAT1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of FAT1 gene CTD PMID:29154799 valproic acid increases expression ISO FAT1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of FAT1 mRNA CTD PMID:23179753 valproic acid decreases expression ISO FAT1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of FAT1 mRNA CTD PMID:29154799 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FAT1 mRNA CTD PMID:29427782 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of FAT1 mRNA CTD PMID:29427782
